Liposomal doxorubicin for treatment of metastatic chemorefractory vulvar adenocarcinoma

Gynecologic Oncology

Volumn 87, Issue 3, 2002, Pages 313-318

  Huang, Gloria S ^a   Juretzka, Margrit ^a   Ciaravino, Giuseppe ^a   Kohler, Sabine ^a   Teng, Nelson N H ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenocarcinoma; Doxorubicin; Extramammary Paget's disease; Liposome; Vulvar neoplasm

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; LIPOSOME; TAMOXIFEN; THALIDOMIDE;

ABDOMEN; AGED; ARTICLE; BEAM THERAPY; BONE METASTASIS; BONE SCINTISCANNING; BRAIN METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CASE REPORT; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; INGUINAL REGION; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENOPATHY; MAMMOGRAPHY; METASTASIS; PAGET SKIN DISEASE; PELVIS; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SKIN METASTASIS; SURGICAL TECHNIQUE; SURVIVAL TIME; THORAX; TREATMENT OUTCOME; TUMOR BIOPSY; UTERINE CERVIX CYTOLOGY; VULVA; VULVA CARCINOMA; VULVECTOMY;

EID: 0036928246     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2002.6830     Document Type: Article

References (27)

1. Berek JS, Hacker NF. Practical gynecologic oncology. Philadelphia: Lippincott Williams & Wilkins, 2000;xix, 937.
2. Copeland LJ, Sneige N, Gershenson DM, McGuffee VB, Abdul-Karim F, Rutledge FN. Bartholin gland carcinoma. Obstet Gynecol 1986;67:794-801.
3. Leuchter RS, Hacker NF, Voet RL, Berek JS, Townsend DE, Lagasse LD. Primary carcinoma of the Bartholin gland: A report of 14 cases and review of the literature. Obstet Gynecol 1982;60:361-8.
4. Curtin JP, Rubin SC, Jones WB, Hoskins WJ, Lewis JL, Jr. Paget's disease of the vulva. Gynecol Oncol 1990;39:374-7.
5. Feuer GA, Shevchuk M, Calanog A. Vulvar Paget's disease: The need to exclude an invasive lesion. Gynecol Oncol 1990;38:81-9.
6. Hart WR, Millman JB. Progression of intraepithelial Paget's disease of the vulva to invasive carcinoma. Cancer 1977;40:2333-7.
7. Parker LP, Parker JR, Bodurka-Bevers D, Deavers M, Bevers MW, Shen-Gunther J, Gershenson DM. Paget's disease of the vulva: Pathology, pattern of involvement, and prognosis. Gynecol Oncol 2000;77:183-9 (doi:10.1006/gyno.2000.5741).
8. Boehm F, Morris JM. Paget's disease and apocrine gland carcinoma of the vulva. Obstet Gynecol 1971;38:185-92.
9. Crawford D, Nimmo M, Clement PB, Thomson T, Benedet JL, Miller D, Gilks CB. Prognostic factors in Paget's disease of the vulva: A study of 21 cases. Int J Gynecol Pathol 1999;18:351-9.
10. van der Putte SC, van Gorp LH. Adenocarcinoma of the mammary-like glands of the vulva: A concept unifying sweat gland carcinoma of the vulva, carcinoma of supernumerary mammary glands and extramammary Paget's disease. J Cutan Pathol 1994;21:157-63.
11. Escalonilla P, Grilli R, Canamero M, Soriano ML, Farina MC, Manzarbeitia F, Sainz R, Matsukura T, Requena L. Sebaceous carcinoma of the vulva. Am J Dermatopathol 1999; 21:468-72.
12. Rich PM, Okagaki T, Clark B, Prem KA. Adenocarcinoma of the sweat gland of the vulva: Light and electron microscopic study. Cancer 1981;47: 1352-7.
13. Rose PG, Roman LD, Reale FR, Tak WK, Hunter RE. Primary adenocarcinoma of the breast arising in the vulva. Obstet Gynecol 1990;76: 537-9.
14. Bolis GB, Maccio T. Clear cell adenocarcinoma of the vulva arising in endometriosis. A case report. Eur J Gynaecol Oncol 2000;21:416-7.
15. Goldblum JR, Hart WR. Vulvar Paget's disease: A clinicopathologic and immunohistochemical study of 19 cases. Am J Surg Pathol 1997;21: 1178-87.
16. Lloyd J, Flanagan AM. Mammary and extramammary Paget's disease. J Clin Pathol 2000;53:742-9.
17. Creasman WT, Gallager HS, Rutledge F. Paget's disease of the vulva. Gynecol Oncol 1975;3:133-48.
18. Wagenaar HC, Colombo N, Vergote I, Hoctin-Boes G, Zanetta G, Pecorelli S, Lacave AJ, van Hoesel Q, Cervantes A, Bolis G, Namer M, Lhomme C, Guastalla JP, Nooij MA, Poveda A, Scotto di Palumbo V, Vermorken JB. Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: An EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer. Gynecol Oncol 2001; 81:348-54 (doi:10.1006/gyno.2001.6180).
19. Thigpen JT, Blessing JA, Homesley HD, Lewis GC, Jr. Phase II trials of cisplatin and piperazinedione in advanced or recurrent squamous cell carcinoma of the vulva: A Gynecologic Oncology Group Study. Gynecol Oncol 1986;23:358-63.
20. Han SC, Kim DH, Higgins SA, Carcangiu ML, Kacinski BM. Chemora-diation as primary or adjuvant treatment for locally advanced carcinoma of the vulva. Int J Radiat Oncol Biol Phys 2000;47:1235-44.
21. Akl A, Akl M, Boike G, Hebert J, Graham J. Preliminary results of chemoradiation as a primary treatment for vulvar carcinoma. Int J Radiat Oncol Biol Phys 2000;48:415-20.
22. Montana GS, Thomas GM, Moore DH, Saxer A, Mangan CE, Lentz SS, Averette HE. Preoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes: A gynecologic oncology group study. Int J Radiat Oncol Biol Phys 2000;48:1007-13.
23. Balducci L, Athar M, Smith GF, Khansur T, McKenzie D, Crawford ED. Metastatic extramammary Paget's disease: Dramatic response to combined modality treatment. J Surg Oncol 1988;38:38-44.
24. Yamamoto R, Sakuragi N, Shirato H, Shimizu M, Fujimoto S. Radiotherapy with concurrent chemotherapy for vulvar adenocarcinoma associated with extramammary Paget's disease. Gynecol Oncol 2001;80:267-71 (doi:10.1006/gyno.2000.6054).
25. Massad LS, De Geest K. Multimodality therapy for carcinoma of the Bartholin gland. Gynecol Oncol 1999;75:305-7 (doi:10.1006/gyno.1999.5542).
26. Kohler S, Smoller BR. Gross cystic disease fluid protein-15 reactivity in extramammary Paget's disease with and without associated internal malignancy. Am J Dermatopathol 1996;18:118-23.
27. Koukourakis MI, Koukouraki S, Fezoulidis I, Kelekis N, Kyrias G, Archimandritis S, Karkavitsas N. High intratumoural accumulation of stealth liposomal doxorubicin (Caelyx) in glioblastomas and in meta-static brain tumours. Br J Cancer 2000;83:1281-6 (doi:10.1054/bjoc.2000.1459).